Stephen Morrison (@steviemo83) 's Twitter Profile
Stephen Morrison

@steviemo83

Server/web/desktop/android/iOS software. Engineering Leader @benchling

ID: 69295688

calendar_today27-08-2009 13:53:08

2,2K Tweet

252 Followers

520 Following

Duncairn Arts (@theduncairn) 's Twitter Profile Photo

The Duncairn Virtual Cabaret - streaming LIVE right now on our Facebook and Youtube! Please contribute at: bit.ly/DVCDonate , all donations will be shared equally among the artists taking part in the project. #duncairncabaret

Oroson (@orosonhq) 's Twitter Profile Photo

Thanks to Failory for including Oroson in their list of 'One's to Watch' for startups in 2020. We are among great company on that list!

Simon Wardley (@swardley) 's Twitter Profile Photo

X : One of our customers wants a new feature in our product. Me : Sounds good. Add it to the backlog. X : No other customer seems to want this. It's unique to them. Me : Is it a generally useful feature that others might want? X : I doubt it Me : Then super low priority.

Stephen Morrison (@steviemo83) 's Twitter Profile Photo

“Angular Roadmap | Past, Present and Future of Angular” by GrapeCity Developer Solutions link.medium.com/QqVLjJxIydb Nice walkthrough of all the major releases

WORKS COFFEE ROASTERS (@workscoffee18) 's Twitter Profile Photo

We are simply devastated that we will no longer have our pitch after this weekend. Six years may not be an era, but it was certainly something special to us that we built from nothing! Our full statement is on Facebook/Instagram.

Benchling (@benchling) 's Twitter Profile Photo

Today, we’re thrilled to announce we’ve acquired Overwatch Research, a Benchling company! With this acquisition, Benchling will create the industry’s first comprehensive, cloud-native in vivo solution and help more #biopharma companies get products to the clinic faster. forbes.com/sites/alexknap… 1/5

Overwatch Research, a Benchling company (@overwatchapp) 's Twitter Profile Photo

We are excited to be at #AACR22 in New Orleans this week. Come find us at Booth 1451 to see how Overwatch can help with all of your #invivo study requirements.

We are excited to be at #AACR22 in New Orleans this week. Come find us at Booth 1451 to see how Overwatch can help with all of your #invivo study requirements.
Benchling (@benchling) 's Twitter Profile Photo

Thanks Fast Company for naming us on the Most Innovative Companies of 2023! We’re honored to be #3 in North America, alongside biotech winners Recursion & Metagenomi, who are pioneering breakthrough innovations for a better world. fastcompany.com/90848912/most-… #FCMostInnovative

Thanks <a href="/FastCompany/">Fast Company</a> for naming us on the Most Innovative Companies of 2023! We’re honored to be #3 in North America, alongside biotech winners <a href="/RecursionPharma/">Recursion</a> &amp; <a href="/metagenomi/">Metagenomi</a>, who are pioneering breakthrough innovations for a better world. fastcompany.com/90848912/most-… #FCMostInnovative
Rod Johnson (@springrod) 's Twitter Profile Photo

1/2 Perhaps surprising opinion: Java is a great language for developing #GenAI apps. Why? 1. Don't need to use Python, as communicating with big models via HTTP is easy in any language. 2. Useful apps often require a bunch of async/persistence stuff where Java beats Python.

PIN (@getpinxyz) 's Twitter Profile Photo

15 most valuable private companies + valuation, from Y Combinator that are yet to IPO: 1. Stripe - $70B 2. Scale AI - $13.8B 3. Rippling - $13.5B 4. Faire - $12.4B 5. Brex - $12.3B 6. Deel - $12B 7. Gusto - $9.5B 8. Flexport - $9B 9. Razorpay - $7.5B 10. Benchling -

15 most valuable private companies + valuation, from Y Combinator that are yet to IPO: 

1. Stripe - $70B 
2. Scale AI - $13.8B
3. Rippling - $13.5B 
4. Faire - $12.4B 
5. Brex - $12.3B 
6. Deel - $12B 
7. Gusto - $9.5B 
8. Flexport - $9B 
9. Razorpay - $7.5B
10. Benchling -
Anthropic (@anthropicai) 's Twitter Profile Photo

Claude can now connect to Benchling, PubMed, and Synapse.org, among other platforms. And our new Agent Skills can help Claude follow scientific protocols and procedures consistently.